Biocon Biologics Limited will have access to 100 million doses of vaccines annually together with the distribution rights to Serum's Vaccine portfolio
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries
Fully equipped labs with 75-member team set-up and made operational in <100 days
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
From cancer research to diagnostic solutions
Affordability is key to providing accessible healthcare for Bharat.
The combination will support clients in getting their end-to-end discovery and development programs delivered.
Subscribe To Our Newsletter & Stay Updated
